The purpose of this work is to review the modern thinking and treatments useful today regarding Acute and Chronic Rhinosinusitis. The term rhinosinusitis is more pertinent than sinusitis alone since the organ of the nose is the mucosa, and the entire nasal and sinus mucosa is often involved in both the acute and chronic inflammatory disease process. Another important purpose of this work is the presentation of the new modern “fungal-immunologic” theory as to the cause of Chronic Rhinosinusitis (CRS) and as a consequence, the new treatment. It is well known that non-viral, acute rhinosinusitis is most often a bacterial disease, which is almost always successfully treated with antibiotics. As of this writing, there is no approved FDA* medical treatment for Chronic Rhinosinusitis (CRS). With the advent of the new modern “fungal-immunologic” theory and the early promising results with antifungal topical treatments, we are optimistic about the future treatments for the chronic form of rhinosinusitis. We await, with great expectation, the results of multi-center clinical trials which are currently in progress. Hopefully this book will quickly inform and update as to this new and modern thinking and the current treatment of both Acute and Chronic Rhinosinusitis. Both are very common and most troubling disorders. Our patients deserve the most modern medical thinking and the most successful medical and surgical treatments have to offer.

Rinosinusite acuta recidivante e cronica/ Acute, recurrent and chronic rhinosinusitis.

LAURIELLO, MARIA;
2008-01-01

Abstract

The purpose of this work is to review the modern thinking and treatments useful today regarding Acute and Chronic Rhinosinusitis. The term rhinosinusitis is more pertinent than sinusitis alone since the organ of the nose is the mucosa, and the entire nasal and sinus mucosa is often involved in both the acute and chronic inflammatory disease process. Another important purpose of this work is the presentation of the new modern “fungal-immunologic” theory as to the cause of Chronic Rhinosinusitis (CRS) and as a consequence, the new treatment. It is well known that non-viral, acute rhinosinusitis is most often a bacterial disease, which is almost always successfully treated with antibiotics. As of this writing, there is no approved FDA* medical treatment for Chronic Rhinosinusitis (CRS). With the advent of the new modern “fungal-immunologic” theory and the early promising results with antifungal topical treatments, we are optimistic about the future treatments for the chronic form of rhinosinusitis. We await, with great expectation, the results of multi-center clinical trials which are currently in progress. Hopefully this book will quickly inform and update as to this new and modern thinking and the current treatment of both Acute and Chronic Rhinosinusitis. Both are very common and most troubling disorders. Our patients deserve the most modern medical thinking and the most successful medical and surgical treatments have to offer.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11697/28145
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact